美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Alternative Access First Priority CLO Bond ETF

24.99

+0.03500.14%

盘后：24.990.00000.00%16:04 EDT

成交量：3,131.00

成交额：7.81万

市值：4,248.30万

市盈率：- -

高：24.99

开：24.95

低：24.93

收：24.96

数据加载中...

总览公司新闻公告

上市2日规模超百亿！科创债ETF招商（551900）单日再获超46亿元资金净申购，居沪深同类第一！

国泰君安资管旗下国泰君安中证同业存单AAA指数7天持有二季度末规模0.63亿元，环比减少34.77%

Calidi Biotherapeutics, Inc.7月17日成交额为211.85万美元

首秀亮眼！科创债ETF华夏（551550）上市首日交易火爆，净流入规模稳居同类第一

Calidi Biotherapeutics, Inc.7月16日成交额为291.82万美元

关于同意国泰海通证券股份有限公司为广发上证AAA科技创新公司债交易型开放式指数证券投资基金提供主做市服务的公告

关于同意申万宏源证券有限公司为鹏华上证AAA科技创新公司债交易型开放式指数证券投资基金提供主做市服务的公告

Calidi Biotherapeutics, Inc.盘中异动早盘急速拉升11.89%

Calidi Biotherapeutics, Inc.7月14日成交额为451.70万美元

Calidi Biotherapeutics, Inc.盘中异动早盘快速跳水8.21%

江苏悦达集团有限公司主体获“AAA”评级

华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级

星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级

东方金诚：维持贵州交通建设集团有限公司主体信用等级为AAA

洛阳国晟投资控股集团有限公司2024年度第一期中期票据跟踪评级获“AAA”评级

中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级

惠誉确认德国的AAA评级。

云南机场集团有限责任公司2022年度第一期中期票据(可持续挂钩)跟踪评级获“AAA”评级

吉林省高速公路集团有限公司2024年面向专业投资者公开发行公司债券(第二期)跟踪评级获“AAA”评级

Calidi Biotherapeutics, Inc.7月10日成交额为1.10亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/AAA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAA\",,,,,undefined,":{"symbol":"AAA","market":"US","secType":"STK","nameCN":"Alternative Access First Priority CLO Bond ETF","latestPrice":24.99,"timestamp":1752868800000,"preClose":24.955,"halted":0,"volume":3131,"hourTrading":{"tag":"盘后","latestPrice":24.99,"preClose":24.99,"latestTime":"16:04 EDT","volume":3,"amount":74.97,"timestamp":1752869047819},"delay":0,"floatShares":1700000,"shares":1700000,"eps":0,"marketStatus":"未开盘","change":0.035,"latestTime":"07-18 16:00:00 EDT","open":24.95,"high":24.99,"low":24.9301,"amount":78143.5392,"amplitude":0.0024,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":24.955,"sharesOutstanding":1700000,"nav":25,"aum":42500000,"dividendRate":0.056823,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.99,"preClose":24.99,"latestTime":"16:04 EDT","volume":3,"amount":74.97,"timestamp":1752869047819},"volumeRatio":0.3788080491258798},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAA\",,,,,undefined,":{"symbol":"AAA","floatShares":1700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3788080491258798,"shares":1700000,"dividePrice":1.42,"high":24.99,"amplitude":0.0024,"preClose":24.955,"low":24.9301,"week52Low":24.33,"pbRate":"--","week52High":25.4,"institutionHeld":0,"latestPrice":24.99,"eps":0,"divideRate":0.056823,"volume":3131,"delay":0,"ttmEps":0,"open":24.95,"prevYearClose":25.075,"prevWeekClose":24.995,"prevMonthClose":24.9643,"prevQuarterClose":24.9643,"fiveDayClose":24.995,"twentyDayClose":25.01,"sixtyDayClose":24.855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553444754","title":"上市2日规模超百亿！科创债ETF招商（551900）单日再获超46亿元资金净申购，居沪深同类第一！","url":"https://stock-news.laohu8.com/highlight/detail?id=2553444754","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553444754?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 09:01","pubTimestamp":1753059719,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["03141","563330","159982","BK4550","09141","399300","BK4588","FDN","BK4585","AAA"],"gpt_icon":0},{"id":"2552544589","title":"国泰君安资管旗下国泰君安中证同业存单AAA指数7天持有二季度末规模0.63亿元，环比减少34.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552544589","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552544589?lang=zh_cn&edition=fundamental","pubTime":"2025-07-20 16:48","pubTimestamp":1753001306,"startTime":"0","endTime":"0","summary":"截至2025年6月30日，国泰君安资管旗下国泰君安中证同业存单AAA指数7天持有期末净资产0.63亿元，比上期减少34.77%，该基金经理为杜浩然。自2023年9月12日起担任“国泰君安中证同业存单AAA指数7天持有期证券投资基金”基金经理。自2023年11月27日起担任“国泰君安君享利30天滚动持有债券型发起式证券投资基金”基金经理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/20164851832426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2552580594","title":"Calidi Biotherapeutics, Inc.7月17日成交额为211.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552580594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552580594?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 09:33","pubTimestamp":1752802422,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Calidi Biotherapeutics, Inc.成交额为211.85万美元，成交额较昨日减少27.40%，当日成交量为353.94万股。Calidi Biotherapeutics, Inc.于2025年7月17日跌2.58%，报0.616美元，该股过去5个交易日跌38.29%，年初至今跌46.44%，过去60日涨39.98%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|211.85万|-27.40%|353.94万|#|2025-07-16|291.82万|9.41%|449.12万|#|2025-07-15|266.73万|-40.95%|502.69万|#|2025-07-14|451.70万|-62.86%|758.74万|#|2025-07-11|1216.10万|-88.92%|1478.40万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093623a6b0df6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093623a6b0df6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2552458597","title":"首秀亮眼！科创债ETF华夏（551550）上市首日交易火爆，净流入规模稳居同类第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458597","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552458597?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 09:23","pubTimestamp":1752801812,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ZNmain","159982","ZFmain","BK4588","UBmain","FDN","BK4585","399923","TNmain","ZTmain","ZBmain","AAA","BK4550","000923.SH","159397"],"gpt_icon":0},{"id":"2552174542","title":"Calidi Biotherapeutics, Inc.7月16日成交额为291.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552174542?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 09:33","pubTimestamp":1752715991,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Calidi Biotherapeutics, Inc.成交额为291.82万美元，成交额较昨日增加9.41%，当日成交量为449.12万股。Calidi Biotherapeutics, Inc.于2025年7月16日涨10.52%，报0.632美元，该股过去5个交易日跌9.69%，年初至今跌45.03%，过去60日涨36.54%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|291.82万|9.41%|449.12万|#|2025-07-15|266.73万|-40.95%|502.69万|#|2025-07-14|451.70万|-62.86%|758.74万|#|2025-07-11|1216.10万|-88.92%|1478.40万|#|2025-07-10|1.10亿|-84.04%|1.17亿|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093621a6ae846e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093621a6ae846e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"gpt_icon":0},{"id":"2552817116","title":"关于同意国泰海通证券股份有限公司为广发上证AAA科技创新公司债交易型开放式指数证券投资基金提供主做市服务的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2552817116","media":"上交所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552817116?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 09:21","pubTimestamp":1752715260,"startTime":"0","endTime":"0","summary":"上证公告（基金）【2025】1073号    为促进广发上证AAA科技创新公司债交易型开放式指数证券投资基金（以下简称科创债基，基金代码:511120）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上市基金做市业务》等相关规定，本所同意国泰海通证券股份有限公司自2025年07月17日起为科创债基提供主做市服务。    特此公告。    上海证券交易所    2025年07月17日                    \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-17/doc-inffttzr3793988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0276","BK0183","BK0184","BK1564","AAA","02611","601211","BK0028","161027","399300","BK0012","BK0188","BK0201","159982","BK1147","000001.SH"],"gpt_icon":0},{"id":"2552171163","title":"关于同意申万宏源证券有限公司为鹏华上证AAA科技创新公司债交易型开放式指数证券投资基金提供主做市服务的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2552171163","media":"上交所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552171163?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 09:18","pubTimestamp":1752715080,"startTime":"0","endTime":"0","summary":"上证公告（基金）【2025】1088号    为促进鹏华上证AAA科技创新公司债交易型开放式指数证券投资基金（以下简称科创债券，基金代码:551030）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上市基金做市业务》等相关规定，本所同意申万宏源证券有限公司自2025年07月17日起为科创债券提供主做市服务。    特此公告。    上海证券交易所    2025年07月17日                    \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-17/doc-inffttzr3791966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399300","BK0028","06806","159982","BK0012","BK0188","BK0276","BK1147","BK1564","161027","AAA","BK0183","000001.SH","000166"],"gpt_icon":0},{"id":"2551263381","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速拉升11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551263381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551263381?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 21:30","pubTimestamp":1752672604,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时30分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅拉升11.89%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1350.49%、873.31%、360.44%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162130049544ea62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162130049544ea62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":1},{"id":"2551324571","title":"Calidi Biotherapeutics, Inc.7月14日成交额为451.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551324571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551324571?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 09:35","pubTimestamp":1752543326,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Calidi Biotherapeutics, Inc.成交额为451.70万美元，成交额较昨日减少62.86%，当日成交量为758.74万股。Calidi Biotherapeutics, Inc.于2025年7月14日跌23.82%，报0.579美元，该股过去5个交易日涨141.25%，年初至今跌49.65%，过去60日涨19.38%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-14|451.70万|-62.86%|758.74万|#|2025-07-11|1216.10万|-88.92%|1478.40万|#|2025-07-10|1.10亿|-84.04%|1.17亿|#|2025-07-09|6.88亿|4742.81%|6.21亿|#|2025-07-08|1420.02万|4150.60%|4652.67万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093742a6a9d9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093742a6a9d9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI","AAA"],"gpt_icon":1},{"id":"2551724181","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘快速跳水8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551724181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551724181?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 21:31","pubTimestamp":1752499877,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时31分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速下跌8.21%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Biomx Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1599.85%、456.46%、301.50%，振幅较大的相关个股有Biomx Inc.、Barinthus Biotherapeutics Plc、Kairos Pharma, Ltd.，振幅分别为9.04%、7.00%、6.89%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213117a6a8efeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213117a6a8efeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"gpt_icon":1},{"id":"2551971723","title":"江苏悦达集团有限公司主体获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551971723","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551971723?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 14:05","pubTimestamp":1752473129,"startTime":"0","endTime":"0","summary":"7月14日，大公国际公布评级报告，江苏悦达集团有限公司主体获“AAA”评级，相关债项获“AAA”评级，评级展望稳定。大公国际资信评估有限公司通过对江苏悦达集团有限公司及“25悦达MTN001”的信用状况进行跟踪评级，确定江苏悦达集团有限公司的主体信用等级维持AAA，评级展望维持稳定，“25悦达MTN001”的信用等级维持AAA。大公国际认为，江苏悦达集团有限公司仍主要从事汽车及智能制造、能源、房地产、供应链等业务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14140551672117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551975114","title":"华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551975114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551975114?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 12:05","pubTimestamp":1752465919,"startTime":"0","endTime":"0","summary":"2025年7月11日，中诚信国际公布评级报告，华侨永亨银行(中国)有限公司2023年绿色金融债券跟踪评级获“AAA”评级。同时中诚信国际也关注到华侨银行中国面临的诸多挑战，包括盈利能力有待提升、贷款行业集中度较高以及存款结构有待改善等。本次评级也考虑了华侨银行集团对该行的支持。中诚信国际认为，华侨银行有限公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14120551670631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA","161121"],"gpt_icon":0},{"id":"2551797511","title":"星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551797511","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551797511?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 12:05","pubTimestamp":1752465918,"startTime":"0","endTime":"0","summary":"2025年7月14日，中诚信国际公布评级报告，星展银行(中国)有限公司2023年金融债券跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论，主要基于星展银行（中国）有限公司（以下称“星展中国”、“该行”或“发行人”）亚洲区域化经营网络和综合性服务平台、较为成熟的运营管理和风险管理技术、较好的资产质量以及较为充足的资本等信用优势。同时中诚信国际也关注到星展中国面临的诸多挑战，包括盈利能力有待提升以及存款结构有待继续优化等。本次评级也考虑了星展集团控股有限公司（以下称“星展集团”或“集团”）对该行的支持。中诚信国际认为，星展银行（中国）有限公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14120551670634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551978252","title":"东方金诚：维持贵州交通建设集团有限公司主体信用等级为AAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978252","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551978252?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 11:05","pubTimestamp":1752462343,"startTime":"0","endTime":"0","summary":"资料显示，贵州交通建设集团有限公司主要从事贵州省内交通基础设施项目的投融资、建设及经营管理，实际控制人为贵州省国资委。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14110551669388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551197827","title":"洛阳国晟投资控股集团有限公司2024年度第一期中期票据跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551197827","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551197827?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 11:05","pubTimestamp":1752462318,"startTime":"0","endTime":"0","summary":"2025年7月11日，中诚信国际公布评级报告，洛阳国晟投资控股集团有限公司2024年度第一期中期票据跟踪评级获“AAA”评级。洛阳国晟投资控股集团有限公司在推进洛阳市城市建设和国有资本运营中发挥重要作用，对洛阳市政府的重要性很高，与洛阳市政府维持紧密关系，获得了政府有力支持。中诚信国际认为，洛阳国晟投资控股集团有限公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14110551669387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2551978201","title":"中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978201","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551978201?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 11:05","pubTimestamp":1752462314,"startTime":"0","endTime":"0","summary":"2025年6月13日，中诚信国际公布评级报告，中国光大银行股份有限公司2025年金融债券(第二期)获“AAA”评级。1997年1月，该行改制成为股份制商业银行，并同时更名为中国光大银行股份有限公司，改制后公司注册资本为人民币28亿元，成为中国国内第一家国有控股并有国际金融组织参股的全国性股份制商业银行。中诚信国际认为，中国光大银行股份有限公司信用水平在未来12~18个月内将保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14110551669393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06818","AAA"],"gpt_icon":0},{"id":"2550964951","title":"惠誉确认德国的AAA评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550964951","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550964951?lang=zh_cn&edition=fundamental","pubTime":"2025-07-12 05:19","pubTimestamp":1752268750,"startTime":"0","endTime":"0","summary":"惠誉确认德国的AAA评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/12051951646684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550024946","title":"云南机场集团有限责任公司2022年度第一期中期票据(可持续挂钩)跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2550024946","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550024946?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 12:05","pubTimestamp":1752206717,"startTime":"0","endTime":"0","summary":"2025年7月10日，中诚信国际公布评级报告，云南机场集团有限责任公司2022年度第一期中期票据跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论，主要基于云南机场集团有限责任公司所处云南省旅游资源丰富且区位优势突出、机场对全省服务覆盖面积大且可形成较好的协同作用，昆明机场枢纽地位高和公司可获得有力的政府支持等方面的优势。中诚信国际认为，云南机场集团有限责任公司信用水平在未来12~18个月内将保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11120551623758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550606526","title":"吉林省高速公路集团有限公司2024年面向专业投资者公开发行公司债券(第二期)跟踪评级获“AAA”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2550606526","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550606526?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 10:05","pubTimestamp":1752199516,"startTime":"0","endTime":"0","summary":"2025年7月10日，中诚信国际公布评级报告，吉林省高速公路集团有限公司2024年面向专业投资者公开发行公司债券(第二期)跟踪评级获“AAA”评级。本次跟踪维持主体及债项上次评级结论。中诚信国际认为吉林省高速公路集团有限公司在推进吉林省高速公路建设及高速公路运营中发挥重要作用，与股东及吉林省政府关联性很高。中诚信国际认为，吉林省高速公路集团有限公司信用水平在未来12~18个月内将保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11100551620546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAA"],"gpt_icon":0},{"id":"2550032046","title":"Calidi Biotherapeutics, Inc.7月10日成交额为1.10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550032046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550032046?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 09:36","pubTimestamp":1752197784,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Calidi Biotherapeutics, Inc.成交额为1.10亿美元，成交额较昨日减少84.04%，当日成交量为1.17亿股。Calidi Biotherapeutics, Inc.于2025年7月10日涨42.57%，报0.998美元，该股过去5个交易日涨326.5%，年初至今跌13.22%，过去60日涨126.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-10|1.10亿|-84.04%|1.17亿|#|2025-07-09|6.88亿|4742.81%|6.21亿|#|2025-07-08|1420.02万|4150.60%|4652.67万|#|2025-07-07|33.41万|150.79%|139.31万|#|2025-07-03|13.32万|5.00%|55.11万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711093654a6a29a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711093654a6a29a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAA\",params:#limit:5,,,undefined,":[{"date":"2025-06-30","symbol":"AAA","amount":0.107424,"announcedDate":"2025-06-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-30","defaultRemindTime":1751290200000,"name":"Alternative Access First Priority CLO Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-30","currency":"USD","dateTimestamp":1751256000000,"payDate":"2025-07-01"},{"date":"2025-05-30","symbol":"AAA","amount":0.11497,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"Alternative Access First Priority CLO Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-02","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-02"},{"date":"2025-04-30","symbol":"AAA","amount":0.10846,"announcedDate":null,"type":"dividend","lastAmount":0.106737,"market":"US","newRecordDate":"2025-04-30","name":"Alternative Access First Priority CLO Bond ETF","lastCurrency":"USD","lastExecuteDate":"2025-03-27","recordDate":"2025-05-01","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-01"},{"date":"2025-03-27","symbol":"AAA","amount":0.106737,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"Alternative Access First Priority CLO Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-28"},{"date":"2025-02-27","symbol":"AAA","amount":0.09469,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-27","defaultRemindTime":1740666600000,"name":"Alternative Access First Priority CLO Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-27","currency":"USD","dateTimestamp":1740632400000,"payDate":"2025-02-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAA\",market:\"US\",,,undefined,":[{"executeDate":"2020-10-01","recordDate":"2020-10-02","paymentDate":"2020-10-05","value":0.013,"currency":"USD"},{"executeDate":"2020-11-02","recordDate":"2020-11-03","paymentDate":"2020-11-04","value":0.0225,"currency":"USD"},{"executeDate":"2020-12-01","recordDate":"2020-12-02","paymentDate":"2020-12-03","value":0.022,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.0231675,"currency":"USD"},{"executeDate":"2021-02-01","recordDate":"2021-02-02","paymentDate":"2021-02-03","value":0.022,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAA\",market:\"US\",delay:false,,,undefined,":{}}}